Company profile ADCT
After 39 days of this quarter the interest is at 92.0. Based on that we can calculate that during remaining 52 days it will total up to 215.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 92 | 136 47.8% QoQ | 154 13.2% QoQ | 80 -48.1% QoQ |
| 2020 | 157 70.7% YoY 96.2% QoQ | 335 146.3% YoY 113.4% QoQ | 341 121.4% YoY 1.8% QoQ | 245 206.2% YoY -28.2% QoQ |
| 2021 | 280 78.3% YoY 14.3% QoQ | 288 -14.0% YoY 2.9% QoQ | 195 -42.8% YoY -32.3% QoQ | 124 -49.4% YoY -36.4% QoQ |
| 2022 | 178 -36.4% YoY 43.5% QoQ | 350 21.5% YoY 96.6% QoQ | 255 30.8% YoY -27.1% QoQ | 223 79.8% YoY -12.5% QoQ |
| 2023 | 273 53.4% YoY 22.4% QoQ | 373 6.6% YoY 36.6% QoQ | 443 73.7% YoY 18.8% QoQ | 350 57.0% YoY -21.0% QoQ |
| 2024 | 92 -66.3% YoY -73.7% QoQ | - | - | - |
The average 5 years interest of ADC Therapeutics was 19.02 per week. The last year interest of ADC Therapeutics compared to the last 5 years has changed by 39.22%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 165.86%.
There is not enough data for ADC Therapeutics ZYNLONTA to provide analysis
There is not enough data for ADC Therapeutics ZYNLONTA to provide correlation calculation
There is not enough data for ADC Therapeutics ZYNLONTA to provide analysis
There is not enough data for ADC Therapeutics clinical trials to provide analysis
There is not enough data for ADC Therapeutics clinical trials to provide correlation calculation
There is not enough data for ADC Therapeutics clinical trials to provide analysis
There is not enough data for ADC Therapeutics lymphoma to provide analysis
There is not enough data for ADC Therapeutics lymphoma to provide correlation calculation
There is not enough data for ADC Therapeutics lymphoma to provide analysis
There is not enough data for ADC Therapeutics camidanlumab tesirine to provide analysis
There is not enough data for ADC Therapeutics camidanlumab tesirine to provide correlation calculation
There is not enough data for ADC Therapeutics camidanlumab tesirine to provide analysis
There is not enough data for ADC Therapeutics hematological malignancies to provide analysis
There is not enough data for ADC Therapeutics hematological malignancies to provide correlation calculation
There is not enough data for ADC Therapeutics hematological malignancies to provide analysis
There is not enough data for ADC Therapeutics solid tumors to provide analysis
There is not enough data for ADC Therapeutics solid tumors to provide correlation calculation
There is not enough data for ADC Therapeutics solid tumors to provide analysis
There is not enough data for ADC Therapeutics cancer to provide analysis
There is not enough data for ADC Therapeutics cancer to provide correlation calculation
There is not enough data for ADC Therapeutics cancer to provide analysis
After 39 days of this quarter the interest is at 110.0. Based on that we can calculate that during remaining 52 days it will total up to 257.0. ADC Therapeutics stock expected interest is significantly higher compared to same quarter last year (+125.4%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 83 | 63 -24.1% QoQ | 130 106.3% QoQ | 113 -13.1% QoQ |
| 2020 | 134 61.4% YoY 18.6% QoQ | 269 327.0% YoY 100.7% QoQ | 126 -3.1% YoY -53.2% QoQ | 128 13.3% YoY 1.6% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 205 -23.8% YoY inf% QoQ | 99 -21.4% YoY -51.7% QoQ | 160 25.0% YoY 61.6% QoQ |
| 2022 | 62 inf% YoY -61.2% QoQ | 173 -15.6% YoY 179.0% QoQ | 231 133.3% YoY 33.5% QoQ | 260 62.5% YoY 12.6% QoQ |
| 2023 | 114 83.9% YoY -56.2% QoQ | 18 -89.6% YoY -84.2% QoQ | 89 -61.5% YoY 394.4% QoQ | 426 63.8% YoY 378.7% QoQ |
| 2024 | 110 -3.5% YoY -74.2% QoQ | - | - | - |
The average 5 years interest of ADC Therapeutics stock was 11.47 per week. The last year interest of ADC Therapeutics stock compared to the last 5 years has changed by 23.71%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 70.76%.
After 39 days of this quarter the interest is at 131.0. Based on that we can calculate that during remaining 52 days it will total up to 306.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 104 | 119 14.4% QoQ | 201 68.9% QoQ | 203 1.0% QoQ |
| 2020 | 126 21.2% YoY -37.9% QoQ | 395 231.9% YoY 213.5% QoQ | 322 60.2% YoY -18.5% QoQ | 324 59.6% YoY 0.6% QoQ |
| 2021 | 278 120.6% YoY -14.2% QoQ | 327 -17.2% YoY 17.6% QoQ | 152 -52.8% YoY -53.5% QoQ | 210 -35.2% YoY 38.2% QoQ |
| 2022 | 171 -38.5% YoY -18.6% QoQ | 307 -6.1% YoY 79.5% QoQ | 251 65.1% YoY -18.2% QoQ | 301 43.3% YoY 19.9% QoQ |
| 2023 | 392 129.2% YoY 30.2% QoQ | 356 16.0% YoY -9.2% QoQ | 469 86.9% YoY 31.7% QoQ | 355 17.9% YoY -24.3% QoQ |
| 2024 | 131 -66.6% YoY -63.1% QoQ | - | - | - |
The average 5 years interest of ADC Therapeutics -company was 21.05 per week. The last year interest of ADC Therapeutics -company compared to the last 5 years has changed by 36.2%. The interest for ADC Therapeutics -company is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 113.0%.